First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.33 CNY -1.4% Market Closed
Updated: May 22, 2024
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
/
Income Statement
/
Research & Development

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Research & Development Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Research & Development
-¥788.9m
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Research & Development
-¥2.1B
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Research & Development
-¥228.3m
CAGR 3-Years
-37%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Research & Development
-¥5B
CAGR 3-Years
3%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Research & Development
-¥329.2m
CAGR 3-Years
-21%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Research & Development
-¥712.5m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Research & Development?
Research & Development
-788.9m CNY

Based on the financial report for Mar 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Research & Development amounts to -788.9m CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-1%

Over the last year, the Research & Development growth was -4%. The average annual Research & Development growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been -6% over the past three years , -1% over the past five years .

ALPHA SPREAD
Join more than 139,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.